qCTG and Doppler Ultrasound in the Detection of Hypoxia Among FGR Fetuses
NCT ID: NCT04447248
Last Updated: 2020-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1714 participants
OBSERVATIONAL
2011-05-05
2019-10-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Doppler at the Diagnosis in Predicting Perinatal Outcomes in Early and Late-onset Fetal Growth Restriction
NCT05696223
Placental Imaging Techniques
NCT06861309
Diastolic Deceleration Area in Late-onset FGR
NCT05837195
COmputerized CTG Self-MOnitoring Versus Standard Doppler Assessment in Late-onset FGR: COSMOS Study
NCT05034861
Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler
NCT05284474
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
QDSP Protocol
Computerized expert system for fetal monitoring, based on cardiotocogrpaphy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* absence of sonographic and laboratory evidence of structural anomalies;
* absence of severe maternal complications;
* documented birth weight \< 10th centile;
* full follow-up documentation
Exclusion Criteria
* congenital malformations and any chromosomal malformations known before labor and delivery;
* severe maternal complications;
* documented birth weight \> 10th centile;
* pregnancy loss;
* failure to obtain full follow-up documentation
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Orthogyn Medical Center, Bulgaria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Petar Ignatov
Assist. Prof. Petar Ignatov, MD, Ph.D.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QDSP Protocol
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.